PURPOSE: To assess the prevalence of @entity302 , and antiepileptic drug (AED) use among nursing home elderly residents; to evaluate demographics, @entity410 characteristics, and @entity410 -related comorbidities associated with institutionalization; and to compare findings with a previous survey conducted 12 years earlier. METHODS: Data on demographics, age at institutionalization, diagnoses, functional and cognitive status (Barthel Index and Mini Mental State Examination) and drug treatment were obtained by review of medical records of all individuals aged >= 60 years at 21 nursing homes. Data from individuals with a diagnosis of @entity302 and AED users were compared with non- @entity410 , non-AED individuals. RESULTS: Among the 2163 individuals surveyed (79% females, age at observation 84.9  7.8 years, mean  SD), 278 (12.8%, vs 4.3% in the previous survey) received chronic AED treatment, including 174 who did not have a diagnosis of @entity410 . Of the 116 residents with a diagnosis of @entity410 (5.4%, vs 2.9% in the previous study), 104 were on AED treatment and were younger and had lower cognitive abilities, and a higher number of comorbidities and co-medications compared with non-AED-users. The most commonly prescribed AEDs in @entity410 individuals were @entity109 (43.3%, vs 70% in the previous survey) and @entity4677 (27.9%, not available at the time of previous survey). At multivariate analysis, a diagnosis of @entity410 was found to be associated with younger age at the time of the survey, a history of neurological (cerebrovascular events, @entity1653 ) and @entity16 ( @entity1569 and chronic @entity3617 ), and a lower MMSE score. CONCLUSIONS: The prevalence of @entity410 and AED use was higher than in our previous survey and more aligned with data from other countries. @entity410 , AED use and co-morbidities were associated with earlier institutionalization. There were indicators of treatment being suboptimal in many cases.

Antiepileptic drug use and XXXX in nursing home residents in the Province of Pavia, Italy: A reappraisal 12 years after a first survey.

@entity3617 :: ('MESH:D001991', 'Disease') :: ['bronchitis'] @entity4677 :: ('MESH:C026098', 'Chemical') :: ['levetiracetam'] @entity410 :: ('MESH:D012640', 'Disease') :: ['seizure', 'Seizures', 'seizures'] @entity1569 :: ('MESH:D011565', 'Disease') :: ['psoriasis'] @entity16 :: ('MESH:D009422', 'Disease') :: ['non-neurological conditions'] @entity1653 :: ('MESH:D008579', 'Disease') :: ['meningiomas'] @entity109 :: ('MESH:D010634', 'Chemical') :: ['phenobarbital'] @entity302 :: ('MESH:D004827', 'Disease') :: ['epileptic seizures']
@entity302 :: (MESH:D004827,Disease) :: ['epileptic seizures']
